Book chapter
Alcohol Use Disorders and Clinical Management
DeckerMed Psychiatry
06/04/2021
DOI: 10.2310/PSYCH.13041
Abstract
Alcohol use disorder (AUD) is the current DSM-5 designation for problematic and pathologic alcohol use. AUDs have a high prevalence in the United States and are commonly treated in psychiatric practice. They are associated with a wide variety of medical and psychiatric comorbidities. Effective treatment depends on tailoring treatment setting, behavioral psychotherapies, and psychotropic interventions to the individual patients. Three medications are Food and Drug Administration approved for the treatment of AUDs: naltrexone, acamprosate, and disulfiram. Several other medications (anticonvulsants and baclofen) have been studied, but their role in treating AUDs is uncertain. Naltrexone and/or acamprosate should be considered first-line medications for patients without contraindications. Disulfiram can be considered a second-line or first-line treatment in patients with appropriate support or those who prefer it. All patients who are diagnosed with AUDs should be referred to mutual support groups (i.e., Alcoholics Anonymous).
This review contains 3 figures, 8 tables, and 38 references.
Key words: acamprosate, Alcoholics Anonymous, AUDIT, brief interventions, disulfiram, gabapentin, naltrexone, topiramate, 12 step
Details
- Title: Subtitle
- Alcohol Use Disorders and Clinical Management
- Creators
- Alexander ThompsonDaniel RohlfJoseph Cocozzella
- Resource Type
- Book chapter
- Publication Details
- DeckerMed Psychiatry
- DOI
- 10.2310/PSYCH.13041
- Language
- English
- Date published
- 06/04/2021
- Academic Unit
- Psychiatry; Emergency Medicine
- Record Identifier
- 9984296256302771
Metrics
38 Record Views